BRAINXELL
BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery. BrainXell was founded in 2015 by Prof. Su-Chun Zhang in conjunction with the Discovery to Product (D2P) program of University of Wisconsin- Madison and operates out of a new facility in University Research Park. The company is based on the proprietary technology of directed differentiation of human stem cells (including induced pluripotent stem cells) to highly enriched subclasses of neurons.
BRAINXELL
Industry:
Biopharma Biotechnology Medical
Founded:
2015-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.brainxell.com
Total Employee:
1+
Status:
Active
Contact:
608-220-3240
Email Addresses:
[email protected]
Total Funding:
13.25 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag
Similar Organizations
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Praxis Precision Medicines
Praxis Precision Medicines offers drug development services.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.brainxell.com
- Host name: 245.232.174.34.bc.googleusercontent.com
- IP address: 34.174.232.245
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
